Bilateral Nongranulomatous Anterior Uveitis with Macular Edema Associated with Ibrutinib Use: A Case Report
This case underscores the importance of recognizing ocular adverse effects associated with ibrutinib therapy. Increased awareness among clinicians may facilitate early diagnosis and timely intervention, thereby improving the visual prognosis of affected patients. Early ophthalmologic evaluation should be considered in individuals receiving ibrutinib who develop visual symptoms.
Authors
- Camilo Andrés Gómez-Durán (ORCID: https://orcid.org/0000-0001-5557-6806)
- María Sofía Morales
- Martha Luz Zuluaga
- Jairo Alonso Gómez Mejía
- Claudia Duran
Institutions
- Universidad El Bosque (CO)
- Ophthalmology Clinic (DE)
- Barraquer Opthalmology Center (ES)
- Hospital de Clínicas (UY)
- Fundación Universitaria Sanitas (CO)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1080/09273948.2025.2603497
- Citations
- 2
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 3.41